News

AI-derived predictive biomarker identifies two thirds of patients with high-risk prostate cancer who may benefit from ...
Jason M. Hafron, MD, discusses IsoPSA, a novel prostate-specific antigen assay for patients with a PSA > 4ng/ml who are ...
Prostate-specific membrane antigen (PSMA) gene expression predicts angiogenesis and response to tyrosine kinase inhibitors (TKIs) in patients with metastatic clear cell renal cell carcinoma (RCC), ...
General Meeting of Hofseth BioCare ASA for 2025 will be held at the company's premises at Keiser Wilhelms gate 24, 6003 Ålesund, on 23 ...